Delivery Order SPE2DB22D2006-SPE2DB24FW2DS
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply OMNIPAQUE 240 MG/ML VIAL 20ML medical products. The contract has a ceiling value of $1,057.05 and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $1,171.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a medical product, with a completion date of February 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order valued at $1,200.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FEUQ4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,164.10. The contract is a Delivery Order under a Firm Fixed Price contract type. The contract has an ultimate completion date of June 3, 2024 and was awarded on May 31, 2024. No set-aside was used for...
This federal contract award, valued at $2,279.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product, with a period of performance through February 16, 2024. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OMNIPAQUE 300 MG/ML PLUSPAK 500ML medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,912.25, and has an ultimate completion date of December 3, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of OMNIPAQUE 300 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $1,652.90. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 19, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,984.20. It is for the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2024 and was awarded on April 8, 2024. This award is part of Amerisourcebergen's larger...
This federal contract award, identified as SPE2DB22D1202|SPE2DB25FUMP9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, with a ceiling value of $1,906.49. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award date is December 13, 2024, and the ultimate completion date is December 16, 2024. This contract is...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 300 MG/ML INFU BTL 100ML, a pharmaceutical product. The total ceiling value of the contract is $1,035.94, with a final completion date of June 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...